Accuray Incorporated's Board approved a 1-for-40 reverse stock split to increase its stock price and comply with Nasdaq's minimum bid price requirement. Effective November 9, 2026, every 40 shares will combine into one, reducing outstanding shares from about 120.2 million to 3 million. The move aims to maintain Nasdaq listing and will not affect shareholders' ownership percentages except for fractional share cash-outs. Adjustments will also apply to equity awards and stock plans.
Accuray Incorporated's upcoming 1-for-40 reverse stock split is notable context for readers. For those following the health sector, here is Pluang's market snapshot as of Nov 05, 2026 04:11 WIB: out of 150 priced US health stocks, 108 rose and 42 fell. Key movers include AHCO at USD 7.35 (+17.04%), ACHC at USD 34.56 (+16.68%), and MRNA at USD 258.08 (+12.97%), with typical hold times ranging from 9 to 58 days and a strong sell bias in order activity.
The global polypropylene market is projected to grow from 102.7 million tons in 2026 to 139.2 million tons by 2032, with a CAGR of 5.14%. Growth is fueled by rising demand for lightweight automotive parts, mono-material flexible packaging, and high-m...
At the 2026 Chery International User Summit, Chery Auto showcased its new physical AI technology built on decades of automotive safety data and engineering. Their CheryMind AI model and CHERY All-World Engine support autonomous robots, robotaxis, and...
NOVAGOLD shareholders approved a transaction for New NOVAGOLD to acquire the remaining 40% interest in the Donlin Gold project from Paulson Advisers, increasing NOVAGOLD's ownership from 60% to 100%. This consolidation makes New NOVAGOLD the ultimate...
Fox Factory Holding Corp. has appointed Troy Henige as its new Chief Technology Officer (CTO) to lead the company's technology vision, strategy, and product roadmap. This new role aims to enhance innovation, connect engineering strengths across the c...
Sandisk Corporation is rated as a Strong Buy with a revised price target of $3,356, reflecting its deep undervaluation in the market. Despite strong Q1 2027 results, the company trades at a very low forward PEG ratio of 0.12x. The analyst estimates a...
